The Neurofibromatosis newsletter provides a complete picture of the Neurofibromatosis market landscape, ongoing clinical trials, pipeline therapies that are exp...
The T cell Lymphoma newsletter encapsulates the cell Lymphoma treatment sphere, including the current, marketed and upcoming, novel drugs in the TCL therapeutic...
Axial Spondyloarthritis market landscape in the newsletter consisting of currently marketed axSpA drugs, market trends, historical and current epidemiology, ong...
The End-Stage Renal Disease newsletter also comprises the End-Stage Renal Disease market landscape, ongoing clinical trials with significant pharmaceuticals inv...
Explore more about the Cocaine Use Disorder condition, its causes, signs and symptoms, epidemiological insights and currently available therapeutic options thro...
The Cardiovascular Disease Devices whitepaper not only carries a snippet as to what are the most potential factors that seem to promote the CVD industry, but al...
The Lupus Nephritis newsletter encompasses the Lupus Nephritis treatment landscape constituting the current, marketed and upcoming, novel drugs in the Lupus Nep...
Neuromyelitis Optica Spectrum Disorder (NMOSD), also known as Devic disease, is a chronic disorder of the brain and spinal cord which causes inflammation in the optic nerve and spinal cord.
Currently, the Neuromyelitis Optica Spectrum Disorder domain constitutes a robust pipeline with more than 20 drugs existing in the NMOSD therapeutic landscape, out of which 3 are marketed, and 17 are under different phases of development.
DelveInsight presents a new addition to its newsletter edition that focuses on the…
Currently, the Neuromyelitis Optica Spectrum Disorder domain constitutes a robust pipeline with more than 20 drugs existing in the NMOSD therapeutic landscape, out of which 3 are marketed, and 17 are under different phases of development.
DelveInsight presents a new addition to its newsletter edition that focuses on the…
The Virtual Clinical Trials whitepaper includes an overview, comparison between traditional and virtual clinical trial, impact of COVID-19 on clinical trial, pa...
The Myelodysplastic Syndrome (MDS) Market Analysis Whitepaper highlights how several emerging therapies in the pipeline might impact the current treatment regim...